Tereos overview
Tereos contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
| Key Contact | Job titleGroup CFO | LocationOrigny-Sainte-Benoite, France | Email |
Job titleInvestment Analyst | LocationOrigny-Sainte-Benoite, France | Email | |
Job titleHead of Energy and Sustainability | LocationOrigny-Sainte-Benoite, France | Email | |
Tereos investment appetite
Strategy
---------
-----------
Venture capital
Region
Asia-Pacific
----------
------
Sector
--------
Biotech / life science
-----------
Tereos fund commitments
Known fund commitments: 2
| Fund | Manager | Commitment date | Commitment size |
|---|---|---|---|
Manager | Commitment date- | Commitment size- | |
Manager | Commitment date- | Commitment size | |
Stories that mention Tereos
Seventure Partners targets over 200 mln euros for health fund
Seventure Partners has raised an undisclosed sum for its second fund focused on the microbiome and health, nutrition and digital/connected health sectors. The target of Health for Life Capital II is over 200 million euros. The fund's investors include an unnamed U.S. based global food ingredient provider.
Seventure Partners collects 24 mln euros for animal health fund
European venture firm Seventure Partners has raised 24 million euros for AVF, a new venture fund focused on animal health. The target is 60 million euros. The fund's investors include Adisseo.
Digital nutrition platform Zipongo grabs $35 mln Series B
Digital nutrition platform Zipongo has raised $35 million in Series B funding. The investors were Seventure Partners, Mayfield and Zaffre Investments, the investment fund of Blue Cross Blue Shield of Massachusetts.
Enterome lands Series D funding
Paris and Cambridge, Massachusetts-based Enterome, a biotech company focused on treating microbiome-associated diseases with a focus on inflammatory bowel diseases and immuno-oncology indications, has secured 32 million euros in Series D funding. The investors were Seventure, Health for Life Capital, LundbeckFonden Ventures, Omnes Capital, Nestlé Health Science, Principia SGR and Bristol-Myers Squibb.
Seventure Partners sells Cambrooke
Seventure Partners has sold Cambrooke Therapeutics to Ajinomoto. No financial terms were disclosed. Based in Ayer, Massachusetts, Cambrooke is a provider of medical nutrition products for patients with serious chronic unmet medical needs.
Seventure Partners funds Machtfit and Push Doctor
Seventure Partners is backing two European digital health startups: Machtfit and Push Doctor. The firm participated in Push Doctor's recent Series B funding round that raised 23.05 million in euros and Machtfit's Series A round that raised 2.2 million euros. Seventure was the lead investor in the Machtfit financing.
Anaeropharma Science nets $13.1 mln
Tokyo-based Anaeropharma Science, a developer of genetically enhanced bacteria to fight tumors, has raised $13.1 million in funding. The investors included Seventure Partners and Novartis Pharma.
Seventure Partners backs Skinjay
Skinjay, a French maker of shower micro-nebulization devices, has raised 3.5 million euros in funding. The investor was Seventure Partners.